Skip to main content
    L

    Longeveron LLC (LGVN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.11
    -0.03 (-1.40%)

    Market Cap: $7.22M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Longeveron LLC (LGVN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Longeveron LLC (LGVN) has a market cap of $7.22M. Its share count is up 1647.72% from a year earlier. It kept -1921.72% of revenue as net income over the last 12 months.

    Total Valuation

    Market Cap$7.22M
    Latest price (Nov 17, 2026)$2.11

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.34% in the quarter ended Sep 30, 2026 and grew 53.50% a year over 2 years.

    Shares Outstanding3.21M
    Shares Change (YoY)+1647.72%
    Shares Change (QoQ)+2.34%
    Share Count Growth (2Y CAGR)+53.50%

    Valuation Ratios

    Sales and book value multiples are 5.8x and 1.4x. Its year-end P/S ranged from 35.2x to 553.0x from 2022 to 2025.

    P/S Ratio5.8x
    Forward P/S4.1x
    P/B Ratio1.4x
    P/TBV Ratio2.7x

    Valuation history and multiples

    Price Statistics

    The stock is down 69.05% over 52 weeks and trades 22.99% below its 50-day average.

    Beta (1Y)0.79
    52-Week Change-69.05%
    1-Month Change+51.80%
    3-Month Change-74.34%
    6-Month Change-68.66%
    5-Year Change-99.52%
    Total Return (1Y)-69.05%
    Total Return (3Y CAGR)-77.68%
    Total Return (5Y CAGR)-68.59%
    Return vs SPY (1Y)-78.59%
    Max Drawdown (1Y)-88.02%
    Max Drawdown (3Y)-99.41%
    Sharpe Ratio (1Y)-0.79
    Correlation with SPY (1Y)0.08
    50-Day Average$2.74
    200-Day Average$6.43
    52-Week Range$1.31 to $12.30
    RSI (14 Days)46.2
    Average Volume (20 Days)100.27K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.25x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.25x
    Quick Ratio1.25x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -475.33% and return on assets is -186.33% over the last 12 months.

    Return on Equity (ROE)-475.33%
    Return on Assets (ROA)-186.33%
    Return on Capital Employed (ROCE)-407.94%
    Asset Turnover0.08x
    Receivables Turnover18.06x

    Scores

    LGVN has an Altman Z-Score of -22.72, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-22.72
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $1.17M over the last 12 months is down 18.93% from the 12 months before.

    Revenue$1.17M
    Revenue Growth (YoY)-18.93%
    Gross Profit$774.00K
    Operating Income-$23.54M
    Pretax Income-$22.39M
    Net Income-$22.39M
    EBITDA-$21.41M
    EBIT-$22.39M
    Reported EPS (TTM)-$4.49

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 39.18% of the $12.02M in total assets.

    Cash and Equivalents$7.25M
    Total Debt$0
    Net Cash$7.25M
    Net Cash Per Share$2.26
    Working Capital$1.62M
    Shareholder Equity$4.71M
    Book Value Per Share$1.47
    Tangible Book Value$2.54M
    Tangible Book Per Share$0.79
    Total Assets$12.02M
    Total Liabilities$7.30M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $232.00K of capital spending, operating cash flow left -$18.24M of free cash flow.

    Operating Cash Flow-$18.01M
    Capital Expenditures$232.00K
    Free Cash Flow-$18.24M
    FCF Per Share-$5.99
    Depreciation and Amortization$977.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2020.77%.

    Gross Margin66.44%
    Operating Margin-2020.77%
    Pretax Margin-1921.72%
    Net Margin-1921.72%
    EBITDA Margin-1837.85%
    EBIT Margin-1921.72%
    FCF Margin-1565.58%
    Gross Margin (5Y Average)52.55%

    Growth

    Revenue fell 0.63% a year over 3 years.

    Revenue Growth (3Y CAGR)-0.63%
    Revenue Growth (5Y CAGR)-26.60%
    Book Value Per Share Growth (2Y CAGR)-70.67%
    Tangible Book Per Share Growth (2Y CAGR)-72.11%

    Revenue and profit by year

    Dividends and Yields

    LGVN does not pay a dividend. Its free cash flow yield is -268.25%.

    FCF Yield-268.25%
    Buyback Yield-32.44%
    Shareholder Yield-32.44%

    Stock Splits

    The last split was a 1-for-10 reverse split on Aug 27, 2026.

    Last Split DateAug 27, 2026
    Split TypeReverse split
    Split Ratio1:10

    Analyst Forecast

    Consensus estimates put revenue growth at 34.96% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+34.96%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LGVN

    What is LGVN's market cap?

    Longeveron LLC has a market cap of $7.22M.

    How many shares of LGVN are outstanding?

    Longeveron LLC has 3.21M shares outstanding. The count is up 1647.72% from a year earlier.

    Does LGVN pay a dividend?

    No. Longeveron LLC does not pay a dividend.

    How much debt does LGVN have?

    Longeveron LLC has $0 of total debt and $7.25M of cash and equivalents, a net cash position of $7.25M.